Advertisement
Questions for management or the Board of Directors may be submittedthrough Monday, September 24 at 5:00 PM Central European Time/11:00 AM EasternTime/8:00 AM Pacific Time to [email protected] [email protected]. For more information about the meeting, pleasevisit the CTI website.Annual Shareholders Meeting Tuesday, September 25 Conference Call 5:00 AM Pacific/ 8:00 AM Eastern / 2:00 PM CET 1-866-551-6755 (US Participants) 800-986980 (Italy) 44-08452450356 (International) Call-back numbers for post listening: 1-866-247-4222 (US Participants) 44-01452-550000 (International) Entry code: 17761691# (English) Entry code: 17759359# (Italian) Live webcast with slides at http://www.cticseattle.com Archived for post viewing approximately 2 hours after the meeting ends Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 Susan Callahan T: 206.272.4472 F: 206.272.4434 E: [email protected] http://www.cticseattle.com/media.htm Investors Contact: Leah Grant T: 206.282.7100 F: 206.272.4434 E: [email protected] http://www.cticseattle.com/investors.htm In Europe Cell Therapeutics Europe S.r.l. Mauro Premi T: +39 02 61035700 F: +39 02 61035601 E: [email protected]
SOURCE Cell Therapeutics, Inc.
